1634-1635 / 1674
University Hospital Erlangen
Hormonal therapy:
Prim (%)
Rec (%)
- Yes
38.7
65.0
- No
47.5
32.7
- Unknown
13.8
2.3
Chemotherapy:
- Yes
35.0
19.8
- No
63.1
78.8
- Unknown
1.8
1.4
Trastuzumab:
-Yes
1.4
1.8
No
98.6
98.2
Breast conserving surgery
100
100
External beam RT
100
0
(Median RT dose (Gy):56 [30 – 69.6)]
(Salvage)-Brachytherapy
0
100
Material & Methods – Patient features
n=217 pts.